According to the ypTNM system after neoadjuvant chemotherapy, 84 (26.5%) patients achieved pCR, 51 (23.4%) patients had HR+ and/or HER2+ tumours, and 33 (33.3%) patients had TN tumours (p = 0.063). Here, ERBB2 is linked to neoplasm.